 SOUTH SAN FRANCISCO, Calif., June 01, 2022 GLOBE NEWSWIRE -- DICE Therapeutics, Inc. Nasdaq: DICE, a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced that management will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 2:30 p.m. ET. 